BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Intelident Solutions Proposes to Acquire Zila (ZILA) for $0.42 per share in Cash


7/8/2009 6:42:15 AM

Bookmark and Share

TAMPA, Fla., July 7 /PRNewswire/ -- Intelident Solutions, Inc. ("Intelident") today announced that it has submitted a proposal to the Board of Directors of Zila, Inc. to acquire all of the common stock of Zila for $0.42 per share, and the preferred stock for $0.48 per share, or a total of approximately $4.4 million.

The proposal represents a premium for common stockholders of more than $418,000, or 10.5%, over the agreement with TOLMAR Holding, Inc. ("Tolmar"), and a premium of 31.3% over Zila's closing common stock price on June 24, 2009. The proposal would also include the purchase of the preferred shares of Zila at a premium of 9.1% over Tolmar's proposal.

"The proposed transaction will create a major dental company in the United States, combining Intelident's leadership in dental practice management with Zila's strength and experience in the prevention, detection, and treatment of oral cancer and periodontal disease," said Intelident CEO Thomas Marler. "This partnership will allow us to introduce a number of new and innovative products while accelerating the growth of the combined enterprise."

Marler continued, "The proposed transaction allows Zila's employees to join a company that is dedicated to advancements in oral care and disease prevention and has a well established reputation in the industry. As one of Zila's largest customers with a unique position as one of the largest dental practice management companies in the United States, we believe we can bring substantial strategic and tactical insight to expanding the sales of Zila's core product lines."

Intelident anticipates the transaction will close in September if its proposal is accepted.

About Intelident Solutions, Inc.

Intelident Solutions is a privately-held company dedicated to advancing the practice of dentistry through innovation and technology. It is the parent company of several dentistry-related enterprises. The company is headquartered in Tampa, Florida.

Important Information

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This press release relates to a business combination transaction with Zila proposed by Intelident, which may become the subject of a registration statement filed with the Securities and Exchange Commission (the "SEC"). This material is not a substitute for the prospectus/proxy statement Intelident would file with the SEC regarding the proposed transaction if such a negotiated transaction with Zila is reached or for any other document which Intelident may file with the SEC and send to Zila stockholders in connection with the proposed transaction. INVESTORS AND SECURITY HOLDERS OF ZILA ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Such documents would be available free of charge through the website maintained by the SEC at www.sec.gov, by calling the SEC at telephone number 800-SEC-0330.

All information in this press release concerning Zila, including its business, operations and financial results, was obtained from public sources. While Intelident has no knowledge that any such information is inaccurate or incomplete, Intelident has not had the opportunity to verify any of that information.

CONTACT: Lauren Key, Vice President, Marketing, Intelident Solutions,
Inc., +1-866-823-8601

Web site: http://www.intelidentsolutions.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES